Drug intelligence / Profile preview

Relactagel

Development stage
Unknown
Lead developer
KoRa Healthcare
Administration
Topical
01

Overview

Relactagel is a vaginal gel developed by KoRa Healthcare for the treatment and prevention of bacterial vaginosis (BV). It is classified as a Class IIa medical device in the European Union and is also marketed as a Natural Health Product in Canada. The formulation contains two primary active components: lactic acid and glycogen. Lactic acid works by restoring and maintaining the physiological vaginal pH (3.8–4.5), which creates an environment unfavorable to the overgrowth of anaerobic bacteria associated with BV. Glycogen serves as a nutrient source for beneficial *Lactobacillus* species, supporting the restoration of a healthy vaginal microbiome. Relactagel is typically administered via pre-filled applicators for a 7-day treatment course to relieve symptoms such as abnormal discharge and odor, and it can be used periodically to prevent recurrence.

Brand names
Relactagel

Beyond the preview

Go deeper on Relactagel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Relactagel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call